Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
Konten disediakan oleh Proactive Investors. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Proactive Investors atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !
Offline dengan aplikasi Player FM !
Tonix Pharmaceuticals CEO Discusses New Long Covid Report and Its Implications
MP3•Beranda episode
Manage episode 432634901 series 2891889
Konten disediakan oleh Proactive Investors. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Proactive Investors atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the implications of a groundbreaking report from the US National Academies of Sciences, Engineering, and Medicine on long Covid. The report defines long Covid as a chronic condition encompassing multiple diagnosable disorders, thus paving the way for better understanding and treatment approaches. A particularly significant finding in the report is the acknowledgment that fibromyalgia can now be diagnosed in patients with long Covid, which eliminates previous diagnostic uncertainties. This development is especially beneficial for Tonix Pharmaceuticals, as the company is advancing TNX-102 SL, a drug designed to treat fibromyalgia. Dr. Lederman pointed out that this new diagnostic clarity could substantially broaden the addressable market for TNX-102 SL, which already targets approximately 10 million American adults diagnosed with fibromyalgia. Tonix Pharmaceuticals is in the final stages of developing TNX-102 SL, having received FDA Fast Track designation in recognition of its significant potential. The company has completed two statistically significant studies and is preparing a new drug application for submission. Dr. Lederman, who has nearly 30 years of experience researching fibromyalgia, emphasized the potential impact of this report on the estimated 14 million Americans suffering from long Covid. This new diagnostic criterion could enable these individuals to access effective treatments for fibromyalgia, representing a significant advancement in patient care. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #TonixPharmaceuticals, #SethLederman, #LongCovid, #Fibromyalgia, #NationalAcademies, #USScience, #TNX102SL, #DrugDevelopment, #FDA, #FastTrack, #Pharmaceuticals, #Health, #MedicalResearch, #Covid19, #ChronicIllness, #Medicine, #Healthcare, #ScientificResearch, #NewDrugApplication, #FibromyalgiaTreatment#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
613 episode
MP3•Beranda episode
Manage episode 432634901 series 2891889
Konten disediakan oleh Proactive Investors. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Proactive Investors atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the implications of a groundbreaking report from the US National Academies of Sciences, Engineering, and Medicine on long Covid. The report defines long Covid as a chronic condition encompassing multiple diagnosable disorders, thus paving the way for better understanding and treatment approaches. A particularly significant finding in the report is the acknowledgment that fibromyalgia can now be diagnosed in patients with long Covid, which eliminates previous diagnostic uncertainties. This development is especially beneficial for Tonix Pharmaceuticals, as the company is advancing TNX-102 SL, a drug designed to treat fibromyalgia. Dr. Lederman pointed out that this new diagnostic clarity could substantially broaden the addressable market for TNX-102 SL, which already targets approximately 10 million American adults diagnosed with fibromyalgia. Tonix Pharmaceuticals is in the final stages of developing TNX-102 SL, having received FDA Fast Track designation in recognition of its significant potential. The company has completed two statistically significant studies and is preparing a new drug application for submission. Dr. Lederman, who has nearly 30 years of experience researching fibromyalgia, emphasized the potential impact of this report on the estimated 14 million Americans suffering from long Covid. This new diagnostic criterion could enable these individuals to access effective treatments for fibromyalgia, representing a significant advancement in patient care. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #TonixPharmaceuticals, #SethLederman, #LongCovid, #Fibromyalgia, #NationalAcademies, #USScience, #TNX102SL, #DrugDevelopment, #FDA, #FastTrack, #Pharmaceuticals, #Health, #MedicalResearch, #Covid19, #ChronicIllness, #Medicine, #Healthcare, #ScientificResearch, #NewDrugApplication, #FibromyalgiaTreatment#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
613 episode
Semua episode
×Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.